A multi-center effectiveness comparison study of fruquintinib with constructed external control cohort of other targeted kinase inhibitors using real-world data in third-line treatment of metastatic colorectal cancer

OBJECTIVE: The objective of this study was to assess the comparative efficacy in third-line setting for metastatic CRC (mCRC) patients using matched population of FRESCO trial with fruquintinib and real-world data with other TKIs. MATERIALS AND METHODS: The arm of fruquintinib from the FRESCO phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ying, Li, Jin, Shen, Lin, Xu, Jianming, Zhang, Yanqiao, Zhang, Jingdong, Pan, Hongming, Qu, Xiujuan, Chen, Yamin, Zhang, Qiang, Li, Jinnan, Sun, Miaomiao, Qin, Shukui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730021/
https://www.ncbi.nlm.nih.gov/pubmed/36505849
http://dx.doi.org/10.3389/fonc.2022.1044328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730021/
https://www.ncbi.nlm.nih.gov/pubmed/36505849
http://dx.doi.org/10.3389/fonc.2022.1044328

Ejemplares similares